Scientists Create Viable Liver Cells in a Lab for HBV Research

— Christine M. Kukka, Project Manager, HBV Advocate

A new technique for studying the lifecycle of HBV could help researchers develop a cure for the disease. In a report published in the Proceedings of the National Academy of Sciences, researchers describe using microfabricated cell cultures to sustain HBV in human liver cells in a lab, which allows them to study how the HBV-infected liver cells respond to drug treatments.

To develop new drugs, researchers need to study how infected liver cells respond to experimental treatments. Until now, researchers have been unable to maintain HBV-infected liver cells in a lab setting. The cells are unstable and need the entire liver to sustain them.

Using a process researchers developed when studying the hepatitis C virus, the researchers developed a system that uses liver cells from livers donated for transplant plus stem cells derived from human skin samples and introduced into the liver-like cells.

Researchers will now use these liver cells to investigate new treatments for HBV.
 
Source: www.yumanewsnow.com/index.php/news/health/7469-model-of-viral-
lifecycle-could-help-in-finding-a-cure-for-hepatitis-b


http://www.hbvadvocate.org/news/HBJ11.9.htm

Labels: ,